← Back
$AKRO All transactions

Akero Therapeutics, Inc.

▼ SELL

$ Value

$80K

Shares

1,453

Price

$55

Filed

Jun 20

Insider

Name

Young Jonathan

Title

Chief Operating Officer

CIK

0001779805

Roles

Officer

Transaction Details

Transaction Date

2025-06-18

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

196,594

Footnotes

Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. Such sales were automatic and not at the discretion of the Reporting Person. | The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $54.33 to $54.84, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. | These shares are held in irrevocable trusts for the benefit of the Reporting Person's children. The Reporting Person's spouse is trustee of the trusts. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Filing Info

Accession No.

0000950170-25-088635

Form Type

4

Issuer CIK

0001744659

Young Jonathan's History

Date Ticker Type Value
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D
2025-12-09 AKRO D

Other Insiders at AKRO (90d)

No other insider activity at this issuer in the last 90 days.